Big Pharma expands into home testing
At-home tests, once considered an anomaly, became de rigueur during the COVID-19 pandemic. Now, as COVID-19 testing rates decline from their pandemic peak, diagnostic companies
At-home tests, once considered an anomaly, became de rigueur during the COVID-19 pandemic. Now, as COVID-19 testing rates decline from their pandemic peak, diagnostic companies